"Pepsinogen C" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
This is one of the 2 related pepsinogen systems in humans. It is found in prostate and seminal fluid whereas PEPSINOGEN A is not.
| Descriptor ID |
D020115
|
| MeSH Number(s) |
D08.622.509.725
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pepsinogen C".
Below are MeSH descriptors whose meaning is more specific than "Pepsinogen C".
This graph shows the total number of publications written about "Pepsinogen C" by people in this website by year, and whether "Pepsinogen C" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pepsinogen C" by people in Profiles.
-
Utilization of an Automated Latex Agglutination Turbidity Assay for Assessing Gastric Mucosal Alteration during Helicobacter pylori Infection. Gut Liver. 2024 01 15; 18(1):60-69.
-
Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations. PLoS One. 2020; 15(4):e0230064.
-
Helicobacter pylori Infection and Gastric Mucosal Atrophy in Two Ethnic Groups in Nepal. Asian Pac J Cancer Prev. 2015; 16(17):7911-6.
-
Establishment of novel in vitro mouse chief cell and SPEM cultures identifies MAL2 as a marker of metaplasia in the stomach. Am J Physiol Gastrointest Liver Physiol. 2014 Oct 15; 307(8):G777-92.
-
Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan. J Gastroenterol Hepatol. 2014 Jan; 29(1):67-73.
-
Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter. 2006 Apr; 11(2):69-74.
-
Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer. 2005 Jun 20; 115(3):463-9.
-
Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointest Endosc. 2001 Oct; 54(4):448-53.
-
Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies. Am J Gastroenterol. 1999 Sep; 94(9):2367-72.